We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+7.09%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.8B
AUM Growth
+$1.26B
(+2.4%)
Cap. Flow
-$756M
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
12.51%
Holding
2,394
New
190
Increased
762
Reduced
1,027
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$173M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$143M |
| 3 |
Blue Owl Capital
OWL
|
+$142M |
| 4 |
Conagra Brands
CAG
|
+$136M |
| 5 |
Lockheed Martin
LMT
|
+$107M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$215M |
| 2 |
PepsiCo
PEP
|
+$200M |
| 3 |
IBM
IBM
|
+$181M |
| 4 |
Merck
MRK
|
+$123M |
| 5 |
TSMC
TSM
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.62% |
| 2 | Technology | 19.5% |
| 3 | Financials | 11.8% |
| 4 | Consumer Discretionary | 8.89% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Puma Biotechnology
PBYI
$496M
| $934K | ﹤0.01% |
307,117
+9,914
| +3% | +$43K |
|
1302
Ameriprise Financial
AMP
$48.2B
| $932K | ﹤0.01% |
3,088
-76
| -2% | -$22.5K |
|
1303
Iron Mountain
IRM
$33.9B
| $928K | ﹤0.01% |
17,725
-3,489
| -16% | -$165K |
|
1304
Perrigo
PRGO
$1.85B
| $928K | ﹤0.01% |
23,859
-1,721
| -7% | -$72.3K |
|
1305
Acadia Healthcare
ACHC
$2.68B
| $927K | ﹤0.01% |
15,268
-4,921
| -24% | -$293K |
|
|
CDK
1306
DELISTED
CDK Global, Inc.
CDK
| $925K | ﹤0.01% |
22,152
+115
| +0.5% | +$4.83K |
|
1307
Workhorse Group
WKHS
$34.6M
| $923K | ﹤0.01% |
+71
| New | +$1.29M |
|
1308
DT Midstream
DTM
$12.7B
| $922K | ﹤0.01% |
19,210
-1,413
| -7% | -$67.7K |
|
1309
Newell Brands
NWL
$2.42B
| $922K | ﹤0.01% |
42,225
+501
| +1% | +$11.3K |
|
|
TWTR
1310
DELISTED
Twitter, Inc.
TWTR
| $920K | ﹤0.01% |
21,283
-72,021
| -77% | -$3.74M |
|
1311
Simply Good Foods
SMPL
$891M
| $917K | ﹤0.01% |
22,054
-14,610
| -40% | -$558K |
|
1312
Merit Medical Systems
MMSI
$5.11B
| $916K | ﹤0.01% |
14,705
+6
| +0% | +$402 |
|
1313
Ingevity
NGVT
$2.36B
| $916K | ﹤0.01% |
12,767
+2,505
| +24% | +$191K |
|
|
ICPT
1314
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $915K | ﹤0.01% |
+56,198
| New | +$947K |
|
|
PSB
1315
DELISTED
PS Business Parks, Inc.
PSB
| $914K | ﹤0.01% |
4,962
+1,308
| +36% | +$230K |
|
1316
Sabra Healthcare REIT
SBRA
$5.16B
| $909K | ﹤0.01% |
67,115
-24,060
| -26% | -$340K |
|
1317
Ziff Davis
ZD
$2.02B
| $909K | ﹤0.01% |
8,206
-4,117
| -33% | -$488K |
|
|
MNRL
1318
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $907K | ﹤0.01% |
43,025
+53
| +0.1% | +$1.16K |
|
1319
Valmont Industries
VMI
$9.19B
| $904K | ﹤0.01% |
3,607
-62,118
| -95% | -$15.2M |
|
1320
Polaris
PII
$3.19B
| $901K | ﹤0.01% |
8,196
-2,269
| -22% | -$267K |
|
1321
Mercury Insurance
MCY
$5.6B
| $895K | ﹤0.01% |
16,856
-1,608
| -9% | -$86.4K |
|
1322
Consolidated Water Co
CWCO
$453M
| $893K | ﹤0.01% |
83,905
-7,600
| -8% | -$84.9K |
|
1323
FTI Consulting
FCN
$3.98B
| $893K | ﹤0.01% |
5,818
-806
| -12% | -$118K |
|
1324
CVR Energy
CVI
$5.38B
| $888K | ﹤0.01% |
+52,818
| New | +$935K |
|
1325
Fox Class B
FOX
$24.5B
| $883K | ﹤0.01% |
25,789
+24,129
| +1,454% | +$883K |
|
Similar funds
Federated Hermes's Q4 2021 Portfolio in Review
As of Q4 2021, Federated Hermes held 2,394 positions worth $53.8B, up 2.4% from $52.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q4 2021 filing shows 190 new, 762 increased, 1,027 reduced and 198 closed positions. Its largest new stake was Conagra Brands: 4,144,058 shares worth $142M. The largest sale was Moderna, an estimated $215M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q4 2021 buy was Conagra Brands: 4,144,058 shares worth $142M.
- Federated Hermes added most to Bristol-Myers Squibb in Q4 2021, an estimated $173M increase.
- Federated Hermes's biggest Q4 2021 reduction was Moderna, cutting an estimated $215M.
- Federated Hermes fully exited GoDaddy in Q4 2021, selling an estimated $77.2M.
- Federated Hermes's ten largest holdings make up 13% of its $53.8B portfolio in Q4 2021.
- Federated Hermes opened 190 new positions and closed 198 in Q4 2021.
- Federated Hermes's portfolio value rose 2.4% quarter-over-quarter to $53.8B.
Based on Federated Hermes's 13F filing for Q4 2021, filed 14 Feb 2022.